Jose G Montoya

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Invasive aspergillosis in the setting of cardiac transplantation
    J G Montoya
    Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305 5107, USA
    Clin Infect Dis 37:S281-92. 2003
  2. ncbi request reprint Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center
    J G Montoya
    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    Clin Infect Dis 33:629-40. 2001
  3. ncbi request reprint Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis
    Jose G Montoya
    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    J Infect Dis 185:S73-82. 2002
  4. pmc VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women
    Jose G Montoya
    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    J Clin Microbiol 40:2504-8. 2002
  5. ncbi request reprint Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America
    Fernando Rosso
    Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    Am J Trop Med Hyg 78:504-8. 2008
  6. pmc Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults
    Cynthia Press
    Toxoplasma Serology Laboratory and Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    J Clin Microbiol 43:3481-3. 2005
  7. doi request reprint Management of Toxoplasma gondii infection during pregnancy
    Jose G Montoya
    Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, USA
    Clin Infect Dis 47:554-66. 2008
  8. pmc Recent developments for diagnosis of toxoplasmosis
    Jack S Remington
    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    J Clin Microbiol 42:941-5. 2004
  9. doi request reprint Changing trends in infectious disease in heart transplantation
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford University, Stanford, California 94305, USA
    J Heart Lung Transplant 29:306-15. 2010
  10. ncbi request reprint Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Dora Y Ho
    Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 94305 5107, USA
    Mycoses 50:227-31. 2007

Collaborators

Detail Information

Publications29

  1. ncbi request reprint Invasive aspergillosis in the setting of cardiac transplantation
    J G Montoya
    Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305 5107, USA
    Clin Infect Dis 37:S281-92. 2003
    ....
  2. ncbi request reprint Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center
    J G Montoya
    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    Clin Infect Dis 33:629-40. 2001
    ....
  3. ncbi request reprint Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis
    Jose G Montoya
    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    J Infect Dis 185:S73-82. 2002
    ..gondii. A summary of the laboratory tests currently available at TSL-PAMFRI for the diagnosis of infection and disease caused by the parasite is presented here...
  4. pmc VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women
    Jose G Montoya
    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    J Clin Microbiol 40:2504-8. 2002
    ..7%) had high-avidity antibodies. These findings highlight the value of the VIDAS IgG avidity kit when used in combination with the TSP to exclude recent infection, especially when only a single serum sample is available...
  5. ncbi request reprint Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America
    Fernando Rosso
    Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    Am J Trop Med Hyg 78:504-8. 2008
    ..6%) survey. In contrast to reports from other regions of the world, Cali has not seen a decrease in T. gondii seroprevalence over the past 25 years...
  6. pmc Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults
    Cynthia Press
    Toxoplasma Serology Laboratory and Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    J Clin Microbiol 43:3481-3. 2005
    ....
  7. doi request reprint Management of Toxoplasma gondii infection during pregnancy
    Jose G Montoya
    Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, USA
    Clin Infect Dis 47:554-66. 2008
    ..Treatment of the infection in the fetus and infant during the first year of life has been demonstrated to significantly improve the clinical outcome...
  8. pmc Recent developments for diagnosis of toxoplasmosis
    Jack S Remington
    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    J Clin Microbiol 42:941-5. 2004
  9. doi request reprint Changing trends in infectious disease in heart transplantation
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford University, Stanford, California 94305, USA
    J Heart Lung Transplant 29:306-15. 2010
    ..This study presents a historical perspective of the changing trends of infectious disease after heart transplantation...
  10. ncbi request reprint Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Dora Y Ho
    Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 94305 5107, USA
    Mycoses 50:227-31. 2007
    ..Combination anti-fungal therapy may be considered for such patients, particularly for those failing single-drug therapy...
  11. pmc Yield of diagnostic procedures for invasive fungal infections in neutropenic febrile patients with chest computed tomography abnormalities
    Dora Y Ho
    Department of Medicine, Division of Infection Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 94305 5107, USA
    Mycoses 54:59-70. 2011
    ..Patients with IFI may not have sinus/chest symptoms, and thus, clinicians should have a low threshold for performing sinus/chest imaging, and if indicated and safe, a biopsy of the abnormal areas...
  12. pmc Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy
    Jose G Montoya
    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA
    J Clin Microbiol 42:4627-31. 2004
    ..g., within 2 to 3 months of sera sampling) suggests a cause other than toxoplasmosis. In such cases, further workup is warranted in order to determine the cause of the lymphadenopathy...
  13. ncbi request reprint Diagnosis and management of toxoplasmosis
    Jose G Montoya
    Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 94305 5107, USA
    Clin Perinatol 32:705-26. 2005
    ....
  14. doi request reprint Utility of DNA sequencing for direct identification of invasive fungi from fresh and formalin-fixed specimens
    Pablo A Moncada
    Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Am J Clin Pathol 140:203-8. 2013
    ..To describe and discuss the utility and potential pitfalls of ribosomal RNA locus sequencing for direct identification of invasive fungi from fresh and formalin-fixed, paraffin-embedded specimens...
  15. doi request reprint Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers
    Tessa Watt
    Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University Medical Center, Palo Alto, CA, USA
    J Med Virol 84:1967-74. 2012
    ..Longer valganciclovir treatment correlated with an improved response...
  16. doi request reprint Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants
    Tudor Rares Olariu
    Toxoplasma Serology Laboratory, Palo Alto Medical Foundation, Palo Alto, CA 94301, USA
    Pediatr Infect Dis J 30:1056-61. 2011
    ..Congenital toxoplasmosis can cause significant neurologic manifestations and other untoward sequelae...
  17. ncbi request reprint Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue
    Andreas M Kogelnik
    Stanford University School of Medicine, Stanford, CA, USA
    J Clin Virol 37:S33-8. 2006
    ..All patients had four or more of the following neurocognitive symptoms: impaired cognitive functioning, slowed processing speed, sleep disturbance, short-term memory deficit, fatigue and symptoms consistent with depression...
  18. doi request reprint Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir
    Stephanie B Troy
    Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California 94305 5107, USA
    Clin Infect Dis 47:e93-6. 2008
    ..Human herpesvirus 6 should be considered in immunocompetent patients with encephalitis...
  19. pmc The differential agglutination test as a diagnostic aid in cases of toxoplasmic lymphadenitis
    Jose G Montoya
    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, CA, USA
    J Clin Microbiol 45:1463-8. 2007
    ..A nonacute pattern in an individual at less than 12 months after COLN should suggest an etiology other than TL. In such cases, investigation for alternative causes, including malignancy, should be instigated...
  20. pmc HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed
    A R Zolopa
    Division of Infectious Diseases and Geographical Medicine, Stanford University School of Medicine, CA 94305, USA
    Ann Intern Med 131:813-21. 1999
    ..Tests for resistance to HIV drugs are available for clinical use; however, their predictive value has not been fully assessed...
  21. pmc Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy
    Joanna M Schaenman
    Department of Medicine, Stanford University School of Medicine, 300 Pasteur Dr, Rm S 100, Stanford, CA 94305, USA
    J Clin Microbiol 43:973-7. 2005
    ..The potential usefulness of plasma voriconazole levels for guiding optimal therapy should be investigated...
  22. doi request reprint Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome
    Jose G Montoya
    Department of Medicine, Stanford University School of Medicine, Stanford, California Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California
    J Med Virol 85:2101-9. 2013
    ..Further investigation with longer treatment duration and a larger sample size is warranted...
  23. ncbi request reprint Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study
    Nina Singh
    Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15240, USA
    Transplantation 81:320-6. 2006
    ..The efficacy of the combination of voriconazole and caspofungin when used as primary therapy for invasive aspergillosis in organ transplant recipients has not been defined...
  24. doi request reprint Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction
    Jose G Montoya
    Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
    J Clin Virol 55:40-5. 2012
    ..Inherited or "chromosomally integrated" HHV-6 (CIHHV-6) is a condition characterized by high DNA loads and germ line transmission of HHV-6 genomes, which are integrated into the telomere...
  25. ncbi request reprint Improving the tools in the fight against cytomegalovirus or strengthening David to defeat Goliath
    Jose G Montoya
    Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    Curr Opin Infect Dis 20:397-8. 2007
  26. ncbi request reprint Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons
    J Lawrence
    Center for AIDS Research at Stanford, Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA
    J Infect Dis 179:1356-64. 1999
    ..These results suggest that nelfinavir may have limited utility after saquinavir failure, particularly without potent concomitant therapy. Combining an NRTI with a new protease inhibitor for rescue may improve response...
  27. pmc Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology
    Elizabeth Ann Stringer
    Department of Anesthesiology, Stanford University School of Medicine, Stanford, CA 94304, USA
    J Transl Med 11:93. 2013
    ..Single time-point approaches potentially overlook important features of CFS, such as fluctuations in fatigue severity. We have observed that individuals with CFS demonstrate significant day-to-day variability in their fatigue severity...
  28. doi request reprint Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution
    Ankur R Sangoi
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Am J Clin Pathol 131:364-75. 2009
    ..While histopathologic identification of fungi in tissue sections and cytologic preparations is prone to error, implementation of a standardized reporting format should improve diagnostic accuracy and prevent adverse outcomes...
  29. ncbi request reprint Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University
    Shao Zhou Gao
    Department of Medicine, Stanford University Medical Center, Stanford, California 94305, USA
    J Heart Lung Transplant 22:505-14. 2003
    ..This study attempts to evaluate the impact of different immunosuppressive regimens, ganciclovir prophylaxis and other potential risk factors in the development of PTLD...